Concepts (125)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Antiphospholipid Syndrome | 1 | 2021 | 533 | 0.57 | Why? |
| Ventilator-Induced Lung Injury | 1 | 2018 | 260 | 0.55 | Why? |
| Dexamethasone | 2 | 2021 | 2055 | 0.41 | Why? |
| Anti-Inflammatory Agents | 2 | 2021 | 6153 | 0.27 | Why? |
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2021 | 229 | 0.20 | Why? |
| Lopinavir | 4 | 2021 | 4308 | 0.19 | Why? |
| Isosporiasis | 1 | 2018 | 3 | 0.19 | Why? |
| Isospora | 1 | 2018 | 5 | 0.19 | Why? |
| Ritonavir | 4 | 2021 | 4212 | 0.19 | Why? |
| Lupus Coagulation Inhibitor | 1 | 2021 | 262 | 0.18 | Why? |
| Paecilomyces | 1 | 2017 | 9 | 0.18 | Why? |
| Iran | 5 | 2021 | 5467 | 0.17 | Why? |
| Thymoma | 1 | 2018 | 47 | 0.17 | Why? |
| Adalimumab | 1 | 2021 | 389 | 0.17 | Why? |
| Immunoglobulin Light Chains | 1 | 2017 | 62 | 0.17 | Why? |
| Interferon beta-1a | 1 | 2020 | 316 | 0.17 | Why? |
| HIV Protease Inhibitors | 1 | 2020 | 434 | 0.16 | Why? |
| Immunoglobulins, Intravenous | 2 | 2020 | 2705 | 0.16 | Why? |
| Granulomatous Disease, Chronic | 1 | 2017 | 60 | 0.16 | Why? |
| Plasmapheresis | 1 | 2020 | 437 | 0.16 | Why? |
| Hemoperfusion | 1 | 2020 | 260 | 0.16 | Why? |
| Receptors, Pattern Recognition | 1 | 2017 | 128 | 0.15 | Why? |
| Snoring | 1 | 2016 | 70 | 0.15 | Why? |
| Budesonide | 1 | 2017 | 192 | 0.15 | Why? |
| Agammaglobulinemia | 1 | 2018 | 213 | 0.15 | Why? |
| Erythrocytes | 1 | 2020 | 617 | 0.14 | Why? |
| Treatment Failure | 1 | 2021 | 2106 | 0.14 | Why? |
| Interferon-beta | 1 | 2020 | 979 | 0.14 | Why? |
| Antigens, Bacterial | 1 | 2017 | 330 | 0.14 | Why? |
| Acinetobacter Infections | 1 | 2017 | 273 | 0.14 | Why? |
| Acinetobacter baumannii | 1 | 2017 | 378 | 0.13 | Why? |
| Tumor Necrosis Factor-alpha | 2 | 2021 | 2483 | 0.13 | Why? |
| Nitric Oxide | 1 | 2020 | 769 | 0.13 | Why? |
| Carbon Dioxide | 1 | 2020 | 917 | 0.13 | Why? |
| Bronchiectasis | 1 | 2018 | 312 | 0.13 | Why? |
| Pulmonary Alveoli | 1 | 2018 | 867 | 0.12 | Why? |
| Ventilator Weaning | 1 | 2017 | 536 | 0.12 | Why? |
| Immune System Diseases | 1 | 2017 | 410 | 0.12 | Why? |
| Sleep Apnea Syndromes | 1 | 2016 | 282 | 0.12 | Why? |
| Renal Replacement Therapy | 1 | 2020 | 1530 | 0.11 | Why? |
| Mycoses | 1 | 2017 | 589 | 0.10 | Why? |
| Pyrazines | 1 | 2021 | 1783 | 0.10 | Why? |
| Amides | 1 | 2021 | 1864 | 0.10 | Why? |
| Mesenchymal Stem Cell Transplantation | 1 | 2021 | 1322 | 0.10 | Why? |
| Hypoxia | 2 | 2021 | 3626 | 0.09 | Why? |
| Antiviral Agents | 5 | 2021 | 41703 | 0.09 | Why? |
| Cytokines | 5 | 2021 | 15010 | 0.09 | Why? |
| Respiration, Artificial | 4 | 2021 | 22116 | 0.09 | Why? |
| Oxygen | 1 | 2020 | 3715 | 0.08 | Why? |
| Drug Combinations | 3 | 2021 | 3852 | 0.08 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.08 | Why? |
| Length of Stay | 2 | 2021 | 11042 | 0.08 | Why? |
| Middle Aged | 14 | 2021 | 270681 | 0.07 | Why? |
| Immunologic Factors | 1 | 2020 | 4206 | 0.07 | Why? |
| Pulmonary Disease, Chronic Obstructive | 2 | 2020 | 3832 | 0.07 | Why? |
| Lung Diseases | 1 | 2017 | 2361 | 0.06 | Why? |
| Drug Therapy, Combination | 3 | 2021 | 7268 | 0.06 | Why? |
| Male | 14 | 2021 | 367725 | 0.06 | Why? |
| Personnel, Hospital | 1 | 2016 | 2273 | 0.06 | Why? |
| Tomography, X-Ray Computed | 4 | 2021 | 25144 | 0.06 | Why? |
| Adult | 12 | 2021 | 244371 | 0.05 | Why? |
| Aged | 10 | 2021 | 215776 | 0.05 | Why? |
| Humans | 21 | 2021 | 930598 | 0.05 | Why? |
| Partial Pressure | 1 | 2020 | 279 | 0.05 | Why? |
| Pilot Projects | 2 | 2021 | 5182 | 0.05 | Why? |
| Female | 13 | 2021 | 380317 | 0.05 | Why? |
| Umbilical Cord | 1 | 2021 | 358 | 0.05 | Why? |
| Vasodilation | 1 | 2020 | 258 | 0.04 | Why? |
| Interleukin-6 | 3 | 2021 | 7522 | 0.04 | Why? |
| Injections, Subcutaneous | 1 | 2020 | 647 | 0.04 | Why? |
| Bacterial Outer Membrane Proteins | 1 | 2017 | 60 | 0.04 | Why? |
| Transplantation, Homologous | 1 | 2021 | 757 | 0.04 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.04 | Why? |
| T-Lymphocytes, Helper-Inducer | 1 | 2020 | 497 | 0.04 | Why? |
| Blood Gas Analysis | 1 | 2020 | 893 | 0.04 | Why? |
| Cross Infection | 1 | 2017 | 8675 | 0.04 | Why? |
| Antibodies, Bacterial | 1 | 2017 | 510 | 0.03 | Why? |
| Prevalence | 1 | 2016 | 25773 | 0.03 | Why? |
| Weight Loss | 1 | 2018 | 826 | 0.03 | Why? |
| Flow Cytometry | 1 | 2020 | 2393 | 0.03 | Why? |
| Case-Control Studies | 2 | 2020 | 17671 | 0.03 | Why? |
| Medical Staff | 1 | 2017 | 723 | 0.03 | Why? |
| Lung | 4 | 2021 | 31049 | 0.03 | Why? |
| Placenta | 1 | 2021 | 1531 | 0.03 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.03 | Why? |
| Treatment Outcome | 3 | 2021 | 51732 | 0.02 | Why? |
| Adaptive Immunity | 1 | 2021 | 2585 | 0.02 | Why? |
| Intensive Care Units | 3 | 2021 | 29594 | 0.02 | Why? |
| Pregnancy | 2 | 2021 | 23879 | 0.02 | Why? |
| Bronchoalveolar Lavage Fluid | 1 | 2017 | 2309 | 0.02 | Why? |
| Biopsy | 1 | 2017 | 2811 | 0.02 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Biomarkers | 2 | 2021 | 23361 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Critical Care | 2 | 2021 | 14081 | 0.02 | Why? |
| Hydroxychloroquine | 2 | 2020 | 12447 | 0.02 | Why? |
| Diarrhea | 1 | 2018 | 2743 | 0.02 | Why? |
| Patient Safety | 1 | 2021 | 4885 | 0.02 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| Adolescent | 3 | 2020 | 86841 | 0.02 | Why? |
| Lymphocytes | 1 | 2017 | 3056 | 0.02 | Why? |
| Sepsis | 1 | 2021 | 3517 | 0.02 | Why? |
| Adenosine Monophosphate | 1 | 2021 | 5652 | 0.02 | Why? |
| Alanine | 1 | 2021 | 5687 | 0.02 | Why? |
| Bacterial Infections | 1 | 2017 | 2229 | 0.02 | Why? |
| Body Mass Index | 1 | 2016 | 4306 | 0.02 | Why? |
| Immunity, Innate | 1 | 2021 | 6570 | 0.01 | Why? |
| Virus Internalization | 1 | 2021 | 7921 | 0.01 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.01 | Why? |
| Neutrophils | 1 | 2017 | 5476 | 0.01 | Why? |
| Logistic Models | 1 | 2016 | 9089 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Pandemics | 3 | 2020 | 389249 | 0.01 | Why? |
| Inflammation | 1 | 2021 | 13255 | 0.01 | Why? |
| Critical Illness | 1 | 2021 | 17281 | 0.01 | Why? |
| Comorbidity | 1 | 2021 | 34796 | 0.01 | Why? |
| Prospective Studies | 1 | 2020 | 43301 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2021 | 48226 | 0.01 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.01 | Why? |
| Surveys and Questionnaires | 1 | 2016 | 43792 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2016 | 53120 | 0.01 | Why? |
| Animals | 1 | 2017 | 78931 | 0.01 | Why? |
| Risk Factors | 1 | 2016 | 71621 | 0.00 | Why? |